A. van der Graaf

Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.

M. Trip, J. Kastelein, E. Stroes, 2008, The Journal of pediatrics.

Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.

J. Kastelein, M. Trip, E. Veltri, 2008, Journal of the American College of Cardiology.

Statin Treatment in Children With Familial Hypercholesterolemia: The Younger, the Better

J. Kastelein, E. de Groot, A. V. van Trotsenburg, 2007, Circulation.

Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia

E. Groot, A. Marais, J. Firth, 2006, Acta paediatrica.

Molecular Basis of Autosomal Dominant Hypercholesterolemia: Assessment in a Large Cohort of Hypercholesterolemic Children

J. Kastelein, F. Wijburg, B. Hutten, 2011, Circulation.

Dyslipidemia of Mothers With Familial Hypercholesterolemia Deteriorates Lipids in Adult Offspring

D. Gaudet, D. Brisson, S. Sivapalaratnam, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia

J. Kastelein, B. Hutten, M. N. Vissers, 2006, Expert review of cardiovascular therapy.

Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.

H. Pijl, R. Roos, J. Romijn, 2009, The Journal of clinical endocrinology and metabolism.

Familial defective apolipoprotein B and familial hypobetalipoproteinemia in one family: two neutralizing mutations.

J. Kastelein, M. Trip, B. Hutten, 2008, Annals of internal medicine.